Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
Will Parsons, Interim Director at Texas Children’s Cancer and Hematology Center, shared a post on LinkedIn:
”We’re proud to recognize the national leadership roles of (pictured L-R) Drs. Titilope Fasipe, Jacquelyn “Jackie” Powers and Venee Tubman in advancing care for children with blood disorders.
• Dr. Titi Fasipe serves as Chair of the National Heart, Lung, and Blood Institute (NHLBI) Sickle Cell Disease Advisory Committee and leads two American Society of Hematology (ASH) initiatives focused on community engagement and quality care.
• Dr. Jackie Powers is Clinical Chair for ASH’s guidelines on pediatric iron deficiency, one of the few national efforts focused on children.
• Dr. Tubman leads ASH’s global guidelines on hydroxyurea dosing and monitoring, helping standardize care for children with chronic blood disorders around the world.
Please join us in celebrating their continued leadership and impact on the lives of children and families affected by blood disorders.
The NHLBI is part of the The National Institutes of Health and is focused on advancing research and education on the prevention and treatment of heart, lung, blood and sleep disorders.
ASH is the world’s largest professional organization dedicated to advancing the understanding, diagnosis, treatment and prevention of blood and bone marrow disorders through transformative research, innovative education, and high-quality, equitable care.
Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center are joining forces to launch the Kinder Children’s Cancer Center in 2026.”
Learn more on this initiative here.
Stay updated on the global initiatives in the World of Hematology with Hemostasis Today.
-
Aug 13, 2025, 09:21VELORA Discover Study Now Enrolling: Advancing Care for Type 1 Von Willebrand Disease
-
Aug 13, 2025, 06:44Chokri Ben Lamine: Causes and Diagnostic Approach to PTT Prolongation
-
Aug 13, 2025, 05:41ISTH 2025 Recorded Sessions Now Available on ISTH Academy
-
Aug 13, 2025, 01:39Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
-
Aug 12, 2025, 20:03David McIntosh Urges WHO, the European Blood Alliance, the International Plasma and Fractionation Association to Stop Opposition to VRCD
-
Aug 13, 2025, 16:24Giuseppe Lippi on Laboratory Diagnostics for Immediate Management of Acute Bleeding
-
Aug 13, 2025, 06:13Pip Nicolson: Understanding VITT From COVID-19 Vaccines
-
Aug 13, 2025, 05:23Baseline Hemoglobin Predicts Outcomes in Acute VTE: Low Hb Linked to Higher Bleeding, Ischemia and Mortality Risk
-
Aug 13, 2025, 04:13Lindsey George on Gene Therapy Transforming Hemophilia Care
-
Aug 13, 2025, 02:26Case Report Alert: Basilar Artery Occlusion in IgA-APS
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025